GE Healthcare Technologies Inc
GEHC79.960USD
+1.720+2.20%
終値 11/25, 16:00（ET）15分遅れの株価
36.42B時価総額
16.43直近12ヶ月PER
詳細情報 GE Healthcare Technologies Inc 企業名
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
GE Healthcare Technologies Incの企業情報
企業コードGEHC
会社名GE Healthcare Technologies Inc
上場日Dec 15, 2022
最高経営責任者「CEO」Mr. Kevin Michael O'Neill
従業員数53000
証券種類Ordinary Share
決算期末Dec 15
本社所在地500 West Monroe Street
都市CHICAGO
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号60661
電話番号18337351139
ウェブサイトhttps://www.gehealthcare.com
企業コードGEHC
上場日Dec 15, 2022
最高経営責任者「CEO」Mr. Kevin Michael O'Neill
GE Healthcare Technologies Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.81K
-4.01%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
64.93K
-1.69%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.13%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
13.61K
+55.32%
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
10.16K
+43.77%
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
9.12K
+51.33%
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
165.00
-86.19%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.81K
-4.01%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
64.93K
-1.69%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.13%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Total Imaging
2.20B
44.02%
Total Ultrasound
1.29B
25.74%
Total PCS
778.00M
15.54%
Total PDx
729.00M
14.56%
Other
6.00M
0.12%
会社から関連データがまだ開示されていません。
事業別
地域別
事業別USD
会社名
収益
比率
Total Imaging
2.20B
44.02%
Total Ultrasound
1.29B
25.74%
Total PCS
778.00M
15.54%
Total PDx
729.00M
14.56%
Other
6.00M
0.12%
株主
更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.37%
Dodge & Cox
6.04%
Capital Research Global Investors
5.48%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Investment Management (US)
4.31%
他の
67.38%
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.37%
Dodge & Cox
6.04%
Capital Research Global Investors
5.48%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Investment Management (US)
4.31%
他の
67.38%
種類
株主統計
比率
Investment Advisor
46.98%
Investment Advisor/Hedge Fund
28.87%
Hedge Fund
3.52%
Research Firm
3.02%
Pension Fund
2.71%
Sovereign Wealth Fund
1.76%
Bank and Trust
1.29%
Insurance Company
0.80%
Individual Investor
0.28%
他の
10.76%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
2388
403.23M
88.52%
+7.08M
2025Q2
2403
369.63M
80.96%
-58.15M
2025Q1
2446
400.73M
87.52%
-35.60M
2024Q4
2344
405.16M
88.60%
-9.34M
2024Q3
2188
396.50M
86.79%
-11.03M
2024Q2
2081
391.61M
85.76%
-10.20M
2024Q1
2000
385.11M
84.39%
-2.29M
2023Q4
1855
385.99M
84.77%
-4.81M
2023Q3
1708
381.18M
83.73%
+1.51M
2023Q2
1574
374.50M
82.34%
-3.85M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
51.90M
11.37%
+696.51K
+1.36%
Jun 30, 2025
Dodge & Cox
23.57M
5.16%
+6.98M
+42.10%
Jun 30, 2025
Capital Research Global Investors
19.97M
4.38%
-1.99M
-9.05%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
24.63M
5.39%
-631.11K
-2.50%
Jun 30, 2025
State Street Investment Management (US)
19.66M
4.31%
+372.75K
+1.93%
Jun 30, 2025
Geode Capital Management, L.L.C.
11.94M
2.62%
+231.30K
+1.97%
Jun 30, 2025
Harris Associates L.P.
9.67M
2.12%
+4.04M
+71.68%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
9.37M
2.05%
-33.12K
-0.35%
Aug 31, 2025
Hotchkis and Wiley Capital Management, LLC
7.20M
1.58%
+1.45M
+25.17%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
6.32M
1.38%
+71.17K
+1.14%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
Invesco S&P Spin-Off ETF
7.25%
Langar Global HealthTech ETF
4.85%
Global X HealthTech ETF
4.73%
Fidelity Digital Health ETF
4.57%
iShares U.S. Medical Devices ETF
4.14%
Absolute Select Value ETF
2.89%
VanEck Morningstar Wide Moat Value ETF
2.61%
VanEck Morningstar Wide Moat ETF
2.4%
Knowledge Leaders Developed World ETF
2.3%
First Trust Indxx Medical Devices ETF
2.25%
詳細を見る
Invesco S&P Spin-Off ETF
比率7.25%
Langar Global HealthTech ETF
比率4.85%
Global X HealthTech ETF
比率4.73%
Fidelity Digital Health ETF
比率4.57%
iShares U.S. Medical Devices ETF
比率4.14%
Absolute Select Value ETF
比率2.89%
VanEck Morningstar Wide Moat Value ETF
比率2.61%
VanEck Morningstar Wide Moat ETF
比率2.4%
Knowledge Leaders Developed World ETF
比率2.3%
First Trust Indxx Medical Devices ETF
比率2.25%
配当金
過去5年間の配当金総支払額は
96.00M
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
Sep 22, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 15, 2023
Oct 19, 2023
Jun 23, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 15, 2023
Jul 20, 2023
Apr 25, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Jun 15, 2023 going ex on May 22, 2023
May 23, 2023
Jun 15, 2023
May 22, 2023
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
よくある質問
GE Healthcare Technologies Incの上位5名の株主は誰ですか？
GE Healthcare Technologies Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は51.90M株を保有しており、これは全体の11.37%に相当します。
Dodge & Coxは23.57M株を保有しており、これは全体の5.16%に相当します。
Capital Research Global Investorsは19.97M株を保有しており、これは全体の4.38%に相当します。
BlackRock Institutional Trust Company, N.A.は24.63M株を保有しており、これは全体の5.39%に相当します。
State Street Investment Management (US)は19.66M株を保有しており、これは全体の4.31%に相当します。
The Vanguard Group, Inc.は51.90M株を保有しており、これは全体の11.37%に相当します。
Dodge & Coxは23.57M株を保有しており、これは全体の5.16%に相当します。
Capital Research Global Investorsは19.97M株を保有しており、これは全体の4.38%に相当します。
BlackRock Institutional Trust Company, N.A.は24.63M株を保有しており、これは全体の5.39%に相当します。
State Street Investment Management (US)は19.66M株を保有しており、これは全体の4.31%に相当します。
GE Healthcare Technologies Incの株主タイプ上位3種は何ですか？
GE Healthcare Technologies Incの株主タイプ上位3種は、
The Vanguard Group, Inc.
Dodge & Cox
Capital Research Global Investors
The Vanguard Group, Inc.
Dodge & Cox
Capital Research Global Investors
GE Healthcare Technologies Inc（GEHC）の株式を保有している機関の数はいくつですか？
2025Q3時点で、GE Healthcare Technologies Incの株式を保有している機関は2388社あり、保有株式の総市場価値は約403.23Mで、全体の88.52%を占めています。2025Q2と比較して、機関の持ち株は7.56%増加しています。
GE Healthcare Technologies Incの最大の収益源は何ですか？
FY2025Q2において、Total Imaging部門がGE Healthcare Technologies Incにとって最大の収益を生み出しており、その金額は2.20Bで、全収益の44.02%を占めています。
